Brief: Dermapharm Holding Raises EBITDA Forecast For The Full Year 2021

Dermapharm Holding SE

16/12/2021 11:10

Dec 16 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * RAISES EBITDA FORECAST FOR FULL YEAR 2021
    * EXECUTIVE BOARD NOW EXPECTS GROUP EBITDA^1 TO GROW BY 70
TO 75
PERCENT COMPARED TO PREVIOUS YEAR (PREVIOUSLY: 50 TO 60 PERCENT)
    * CONFIRMS REVENUE FORECAST FOR 2021 FINANCIAL YEAR OF 15 TO
20
PERCENT GROWTH
    * MANAGEMENT BOARD ANALYSED BUSINESS DEVELOPMENT IN NOVEMBER
ON
BASIS OF PRELIMINARY FIGURES IN ITS MANAGEMENT BOARD MEETING
TODAY AND DECIDED TO ADJUST FORECAST FOR FINANCIAL YEAR 2021

Source text for Eikon:  ID:nEQbFrZN7a 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))